Finance

Lists
MCK:NYSE
McKesson Corp
US$ ८६५.६७
+०.७९%
(+६.७७) 1D
अगस्ट २४, १३:५१:३१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCK...
Open
US$ ८६१.४७
High
US$ ८७४.९९
Low
US$ ८५९.७५
Mkt. cap
१.०१ खरब
Avg. vol.
९.८९ लाख
Volume
२.४० लाख
Dividend
०.४३%
Quarterly dividend
US$ ०.९४
Ex-dividend date
२०२६ सेप्टेम्बर १
P/E ratio
२३.१८
52-wk high
US$ ९९९.००
52-wk low
US$ ६७३.३८
EPS
US$ ३७.३५
Beta
०.३०
Shares outstanding
११.६६ करोड
No. of employees
४२ हजार
Open
US$ ८६१.४७
High
US$ ८७४.९९
Low
US$ ८५९.७५
Mkt. cap
१.०१ खरब
Avg. vol.
९.८९ लाख
Volume
२.४० लाख
Dividend
०.४३%
Quarterly dividend
US$ ०.९४
Ex-dividend date
२०२६ सेप्टेम्बर १
P/E ratio
२३.१८
52-wk high
US$ ९९९.००
52-wk low
US$ ६७३.३८
EPS
US$ ३७.३५
Beta
०.३०
Shares outstanding
११.६६ करोड
No. of employees
४२ हजार
News stories
From web sources and news partners
Ad-hoc-news.de
Ad-hoc-news.de
·
२४ मिनेट पहिले
McKesson stock gains as fresh earnings beat and higher dividend support outlook
Barchart.com
Barchart.com
·
३ घण्टा पहिले
McKesson Stock Outlook: Is Wall Street Bullish or Bearish?
TipRanks
TipRanks
·
२ दिन पहिले
McKesson Earnings Call Signals Robust Growth Ahead
TradingKey
TradingKey
·
२ दिन पहिले
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
About McKesson Corp
CEOBrian S. Tyler
Employees४२.३ हजार
Founded१८३३
Headquarters-
Sector-
Websitemckesson.com
Analyst ratings
Based on 13 analysts giving stock ratings to MCK in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for MCK in the last 3 months.
Highest
Current US$ ८६५.६७
US$ १,०८०.०० (+२४.७६%)
Average
US$ ९८७.७५ (+१४.१०%)
Lowest
US$ ८४५.०० (-२.३९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Hold
Initiated
US$ ८४५.००
-२.४%
08/19/2026
Glen Santangelo
Barclays
Buy
Maintained
US$ १,०००.००
+१५.५%
08/18/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
US$ १,०४२.००
+२०.४%
08/10/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
US$ ९३३.००
+७.८%
08/11/2026
Daniel Grosslight
Citi
Buy
Reiterated
US$ १,०००.००
+१५.५%
08/10/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
US$ १,०१५.००
+१७.३%
08/06/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$ १,०००.००
+१५.५%
08/06/2026
Kevin Caliendo
UBS
Buy
Maintained
US$ १,०८०.००
+२४.८%
08/06/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
US$ ९७७.००
+१२.९%
08/07/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
US$ १,०५०.००
+२१.३%
08/06/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
US$ ९०५.००
+४.५%
08/05/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
US$ १,००६.००
+१६.२%
08/06/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/05/2026
George Hill
Deutsche Bank
Buy
Maintained
US$ ८७५.००
+१.१%
05/08/2026
Max Smock
William Blair
Buy
Reiterated
-
-
05/08/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q1 2027
EPS / Est. (USD)
US$ ९.९३ / US$ ९.५४
+४.१४%beat
Revenue / Est. (USD)
१.०५ खरब / १.०४ खरब
+१.५८%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.०३ खरब
१.०६ खरब
९६.३० अरब
१.०५ खरब
Cost of goods sold
९९.६१ अरब
१.०२ खरब
९२.२५ अरब
१.०२ खरब
Cost of revenue
९९.६१ अरब
१.०२ खरब
९२.२५ अरब
१.०२ खरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.१२ अरब
२.०३ अरब
१.९२ अरब
२.२६ अरब
Operating expense
२.१२ अरब
२.०३ अरब
१.९२ अरब
२.२६ अरब
Total operating expenses
१.०२ खरब
१.०५ खरब
९४.१७ अरब
१.०४ खरब
Operating income
१.४२ अरब
१.६४ अरब
२.१३ अरब
१.४२ अरब
Other non operating income
६.२० करोड
७.४० करोड
-१५.६० करोड
६.६० करोड
EBT including unusual items
१.४० अरब
१.६३ अरब
२.१२ अरब
१.३१ अरब
EBT excluding unusual items
१.४० अरब
१.६५ अरब
२.१० अरब
१.४१ अरब
Income tax expense
२३.२० करोड
३८.०० करोड
२७.०० करोड
२७.६० करोड
Effective tax rate
१६.६३%
२३.३१%
१२.७१%
२१.१०%
Other operating expenses
-
-
-
-
Net income
१.११ अरब
१.१९ अरब
१.६८ अरब
६१.४० करोड
Net profit margin
१.०८%
१.१२%
१.७५%
०.५८%
Earnings per share
९.८६
९.३४
११.६९
९.९३
Interest and investment income
-
-
१७.९० करोड
-
Interest expense
-७.४० करोड
-६.३० करोड
-६.१० करोड
-७.७० करोड
Net interest expenses
-७.४० करोड
-६.३० करोड
११.८० करोड
-७.७० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.६० अरब
१.८३ अरब
२.१९ अरब
१.६२ अरब
Gain or loss from assets sale
-१०.२० करोड
-
-४८.८० करोड
-६०.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू